Skip to main content
SpringerLink
Log in

Drugs with Quinine-like Action

  • Chapter
Antimalarial Drug II

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 68 / 2))

Abstract

The drugs to be discussed in this chapter all belong to the general chemical class arylaminoalcohols, and are related structurally to quinine. It is customary to refer to them as derivatives of methanol and they are further classified according to their particular aromatic ring system, e.g. quinolinemethanols, phenanthrenemethanols, pyridinemethanols, etc. Since all of the arylaminoalcohols discussed in this chapter were developed in the US Army programme at the Walter Reed Army Institute of Research and since only two have been officially named, they are referred to by their Walter Reed (WR) numbers. The antimalarial arylaminoalcohols have been reviewed previously (Rozman and Canfield 1979; Canfield 1980; Sweeney 1981).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  • Agharkar S, Lindenbaum S, Higuchi T (1976) Enhancement of solubility of drug salts by hydrophilic counterions:properties of organic salts of an antimalarial drug. J Pharm Sci 65:747–749

    PubMed  CAS  Google Scholar 

  • Antuíiano FJL, Wernsdorfer WH (1979) In vitro response of chloroquine-resistant Plasmodiuom falciparum to mefloquine. Bull WHO 57:663–665

    Google Scholar 

  • Arnold JD, Martin DC, Carson PE, Rieckmann KH, Willerson Jr D, Clyde DF, Miller RM (1973) A phenanthrene methanol (WR 33,063) for treatment of acute malaria. Antimicrob Agents Chemother 3:207–213

    PubMed  CAS  Google Scholar 

  • Aviado DM, Belej M (1970) Pharmacology of new antimalarial drugs. Pharmacology 3:257–272

    PubMed  CAS  Google Scholar 

  • Bay WW, Gleiser CA, Dukes TW, Brown RS (1970) The experimental production and evaluation of drug-induced phototoxicity in swine. Toxicol Appl Pharmacol 17:538–547

    PubMed  CAS  Google Scholar 

  • Blumbergs P, Ao M-S, LaMontagne MP, Markovac A (1975) Antimalarials. 7. 2,8-bis(-tri-fluoromethyl)-4-quinolinemethanols. J Med Chem 18:1122–1126

    PubMed  CAS  Google Scholar 

  • Bouwsma OJ, Stewart JT (1976) Fluorometric determination of WR-148,946 [alpha-di-nbutylaminomethyl)-2,6-bis(trifluoromethylphenyl)-4-pyridine methanol hydrochloride in biological fluids. Anal Lett 9:1003–1013

    CAS  Google Scholar 

  • Brossi A (1976) The present status of malaria chemotherapy. Heterocycles 5:631–647

    CAS  Google Scholar 

  • Brown RE, Stancato FA, Wolfe AD (1979) The effects of mefloquine on Escherichia coli. Life Sci 25:1857–1864

    PubMed  CAS  Google Scholar 

  • Caldwell RW, Nash CB (1977) Pulmonary and cardiovascular effects of mefloquine methanesulfonate. Toxicol Appl Pharmacol 40:437–448

    PubMed  CAS  Google Scholar 

  • Canfield CJ (1980) Antimalarial aminoalcohol alternatives to mefloquine. Acta Tropica 37:232–237

    PubMed  CAS  Google Scholar 

  • Canfield CJ, Hall AP, MacDonald BS, Neumann DA, Shaw JA (1973) Treatment of falciparum malaria from Vietnam with a phenanthrene methanol (WR 33,063) and a quinoline methanol (WR 30,090). Antimicrob Agents Chemother 3:224–227

    PubMed  CAS  Google Scholar 

  • Carroll FI, Blackwell JT (1974) Optical isomers of aryl-2-piperidylmethanol antimalarial agents. Preparation, optical purity, and absolute stereochemistry. J Med Chem 17:210–291

    PubMed  CAS  Google Scholar 

  • Cheng CC (1971) Structure and antimalarial activity of aminoalcohols and 2-(p-chlorophenyl)-2-(4-piperidyl) tetrahydrofuran. J Pharm Sci 60:1596–1598

    PubMed  CAS  Google Scholar 

  • Chevli R, Fitch CD (1981) The antimalarial drug, mefloquine, binds to normal erythrocyte membranes. Fed Proc 40:776

    Google Scholar 

  • Chien P-L, Cheng CC (1973) Further side-chain modification of antimalarial phenanthrene amino alcohols. J Med Chem 16:1093–1096

    PubMed  CAS  Google Scholar 

  • Chien P-L, Cheng CC (1976) Difference in antimalarial activity between certain amino alcohol diastereomers. J Med Chem 19:170–172

    PubMed  CAS  Google Scholar 

  • Chung H, Gillum HH, Rozman RS (1976) The absorption, distribution and elimination of threo-a-(2-piperidyl)-2-trifluoromethyl-6-(4-trifluoromethy]phenyl)-4-pyridinemethanol phosphate (WR 180,409 H3PO4) in mice. Fed Proc Fed Am Soc Exp Biol 35:328

    Google Scholar 

  • Chung H, Gillum HH, Rozman RS (1978) The disposition of threo-a-(2-piperidy1)-2trifluoromethyl-6-(4-trifluoromethylphenyl)-4-pyridinemethanol phosphate in mice. Drug Metab Dispos 6:82–86

    PubMed  CAS  Google Scholar 

  • Chung H, Jimmerson V, Bounds D, Keller R, Rozman R (1979) The disposition of threoa-(2-piperidyl)-2,8-bis(trifluoromethyl)-4-quinolinemethanol hydrochloride (WR 177,602 HCl) in mice. Toxicol Appl Pharmacol 48:1, part 2, A10

    Google Scholar 

  • Chung H, Jimmerson VR, Sanders JE, Bounds DW, Rozman RS, Thorne J (1981) The disposition of dl-3-di-n-butylamino-l-[2,6-bis(4-trifluoromethylphenyl)-4-pyridyl] propanol methanesulfonate in mice. Drug Metab Dispos 9:65–66

    PubMed  CAS  Google Scholar 

  • Clyde DF, McCarthy VC, Rebert CC, Miller RM (1973) Prophylactic activity of a phenanthrene methanol (WR33,063) and a quinoline methanol (WR30,090) in human malaria. Antimicrob Agents Chemother 3:220–223

    PubMed  CAS  Google Scholar 

  • Clyde DF, McCarthy VC, Miller RM, Hornick RB (1976) Suppressive activity of meflo- quine in sporozoite-induced human malaria. Antimicrob Agents Chemother 9:384–386

    PubMed  CAS  Google Scholar 

  • Coatney GR, Cooper WC, Young MD, Burgess RW (1947) Human malaria IV. The suppressive action of a phenanthrene amino alcohol, NIH-204(SN-1796), against sporozoite-induced vivax malaria. Am J Hyg 46:132–140

    PubMed  CAS  Google Scholar 

  • Coatney GR, Cooper WC, Eddy NB, Greenburg J (1953) Survey of antimalarial agents. In: Public health monograph No 9, U.S. Government Printing Office. Washington

    Google Scholar 

  • Colwell WT, Brown V, Christie P, Lange J, Reece C, Yamamoto K, Henry DW (1972) Antimalarial arylaminopropanols. J Med Chem 15:771–775

    PubMed  CAS  Google Scholar 

  • Davidson DE Jr, Johnson DO, Tanticharoenyos P, Hickman RL, Kinnamon KE (1976) Evaluating new antimalarial drugs against trophozoite-induced Plasmodium cynomolgi malaria in rhesus monkeys. Am J Trop Med Hyg 25:26–33

    PubMed  CAS  Google Scholar 

  • Davidson MW, Griggs Jr BG, Boykin DW, Wilson WD (1975) Mefloquine, a clinically useful quinolinemethanol antimalarial which does not significantly bind to DNA. Nature 254:632–634

    PubMed  CAS  Google Scholar 

  • Davidson MW, Griggs BG, Boykin DW, Wilson WD (1977) Molecular structural effects involved in the interaction of quinolinemethanolamines with DNA. Implications for antimalarial action. J Med Chem 20:1117–1122

    PubMed  CAS  Google Scholar 

  • Davies EE, Warhurst DC, Peters W (1975) The chemotherapy of rodent malaria, XXI Action of quinine and WR122,455 (a 9-phenanthrenemethanol) on the fine structure of Plasmodium berghei in mouse blood. Ann Trop Med Parasitol 69:147–153

    PubMed  CAS  Google Scholar 

  • Desjardins RE, Canfield CJ, Haynes JD (1979a) Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother 16:710–718

    PubMed  CAS  Google Scholar 

  • Desjardins RE, Pamplin CL III, von Bredow J, Barry KG, Canfield CJ (1979b) Kinetics of a new antimalarial, mefloquine. Clin Pharmacol Ther 26:372–379

    PubMed  CAS  Google Scholar 

  • Doberstyn EB, Phintuyothin P, Noeypatimanondh S, Teerakiartkomjorn C (1979) Single dose therapy of falciparum malaria with mefloquine or pyrimethamine sulfadoxine. Bull WHO 57:275–279

    PubMed  CAS  Google Scholar 

  • Einheber A, Palmer DM, Aikawa M (1976) Plasmodium berghei:Phase contrast and electron microscopical evidence that certain antimalarials can both inhibit and reverse pigment clumping caused by chloroquine. Exp Parasitol 40:52–61

    PubMed  CAS  Google Scholar 

  • Fitch CD (1969) Chloroquine resistance in malaria:a deficiency of chloroquine binding. Proc Nat Acad Sci USA 64:1181–1187

    PubMed  CAS  Google Scholar 

  • Fitch CD (1972) Chloroquine resistance in malaria:drug binding and cross resistance patterns. Proc Helminthol Soc Washington [Special Issue] 39:265–271

    CAS  Google Scholar 

  • Fitch CD (1977) Chloroquine susceptibility in malaria:dependence on exposure of the parasites to the drug. Life Sci 21:1511–1514

    PubMed  CAS  Google Scholar 

  • Fitch CD, Chan RL, Chevli R (1979) Chloroquine resistance in malaria:accessibility of drug receptors to mefloquine. Antimicrob Agents Chemother 15:258–262

    PubMed  CAS  Google Scholar 

  • Galbraith WM, Campbell S, Tillery K, Mellett LB (1976) Disposition of WR-180,409 H3PO4 in the rat. Fed Proc Fed Am Soc Exp Biol 35:488

    Google Scholar 

  • Grethe G, Mitt G (1978) Verfahren zur Herstellung von Mefloquin. Ger Offen 2. 806, 909

    Google Scholar 

  • Grindel JM, Rozman RS, Leahy DM, Molek NA, Gillum HH (1976) The absorption, distribution, and excretion in mice of a quinolinemethanol antimalarial 2,8-bis(-trifluoromethyl)-4-[1-hydroxy-3-(N-t-butylamino)propyl] quinoline phosphate (WR-184,806). Drug Metab Dispos 4:133–139

    PubMed  CAS  Google Scholar 

  • Grindel JM, Tilton PF, Shaffer RD (1977) Quantitation of the antimalarial agent, mefloquine in blood plasma, and urine using high-pressure liquid chromatography. J Pharm Sci 66:834–837

    PubMed  CAS  Google Scholar 

  • Hacker MP, Hong C-B, Ellis ER, Liu GK, Lee CC (1978) Local venous toxicity of a-(2piperidyl)-2,8-bis(trifluoromethyl)-4-quinolinemethanol methanesulfonate, Mefloquine CH3SO3H (WR-142,490 CH3SO3H) and 2,8-bis(trifluoromethyl)4-[1-hydroxy-3-(N-tbytylamino)-propyl]-quinoline phosphate (WR-184,806 H3PO4) in rabbits. Interim Report No. 137, U.S. Army medical research and development command contract No. DAMD-17–74-C-4036, Jan 12

    Google Scholar 

  • Hahn FE (1974) Chloroquine (resochin). In: Corcoran JW, Hahn FE (eds) Antibiotics, vol III. Springer, Berlin Heidelberg New York, p 58

    Google Scholar 

  • Hahn FE, Fean CL (1969) Spectrophotometric studies of the interaction of an antimalarial quinoline methanol with deoxyribonucleic acid. Anticrob Agents Chemother 4:63–66

    Google Scholar 

  • Hall AP (1976) The treatment of malaria. Br Med J 1:323–328

    PubMed  CAS  Google Scholar 

  • Hall AP, Segal HE, Pearlman EJ, Phintuyothin P (1975) Comparison of a 9-phenanthrene methanol (WR-33,063), a 4-quinoline methanol (WR-30,090) and quinine for falciparum malaria in Thailand. Trans R Soc Trop Med Hyg 69:342–349

    PubMed  CAS  Google Scholar 

  • Hall AP, Doberstyn EB, Karnchanachetanee C, Samransamruajkit S, Laixuthai B, Pearlman EJ, Lampe RM, Miller CF, Phintuyothin P (1977) Sequential treatment with quinine and mefloquine or quinine and pyrimethamine-sulfadoxine for falciparum malaria. Br Med J 1:1626–1628

    PubMed  CAS  Google Scholar 

  • Harmon RE, Lin TS, Gupa SK (1973) Preparation and antimalarial activity of some derivatives of 6-bromo-a-(di-n-heptylaminomethyl)-9-phenanthrenemethanol. J Med Chem 16:940–942

    PubMed  CAS  Google Scholar 

  • Hemwall E, DiPalma JR (1979) Cardiovascular and antiarrhythmic effects of mefloquine. Pharmacologist 21:200

    Google Scholar 

  • Higuchi T, Haslam JL (1974a) Determination of a preferred salt form of WR-180,409 (free base). Interim Report No.7, U.S. Army medical research and development command contract No. DADA17–73-C-3125, September

    Google Scholar 

  • Higuchi T, Haslam JL (1974b) Determination of a preferred salt form of WR-172,435 (free base). Interim Report, U.S. Army medical research and development command contract No. DADA17–73-C-3125, February, Revised November 1975

    Google Scholar 

  • Hiremath CB (1974) Absorption, distribution, and excretion of a-(2-di-n-butylaminoethyl)-1,3,dichloro-6-trifluoromethyl-9-phenanthrene methanol-C14) in rats and rhesus monkeys. Fed Proc Fed Am Soc Exp Biol 33:472

    Google Scholar 

  • Hiremath CB (1975a) Pharmacokinetics and metabolism of candidate antimalarial drugs (WR-171,669-C14, WR-159,412-C14, WR-33,063-C14, WR-172,435-C14, and WR-184,806-C14) in experimental animals. Final report, U.S. Army medical research and development command contract No. DADA-17–72-C-2166, July 15

    Google Scholar 

  • Hiremath CB (1975b) Metabolism and disposition of 3-di-n-butylamino-l-[2,6-bis(4trifluoromethylphenyl)-4-pyridyl] propanol-1-C14 hydrochloride (WR-172,435-C14) in the rat. Fed Proc Fed Am Soc Exp Biol 34:733

    Google Scholar 

  • Hodgson JR, Kowalski MA, Goethem VD, Hainje M, Lee CC (1977a) Mutagenicity studies on 2,8-bis(trifluoromethyl)-4-[1-hydroxy-3-(N-t-butylamino) propyl] quinoline phosphate (WR-184,806 H3PO4). Interim report No. 125, U.S. Army medical research and development command contract No. DAMD-17–74-C-4036

    Google Scholar 

  • Hodgson JR, Lowalski MA, Goethem VD, Hainje M, Lee CC (1977b) Mutagenicity studies on a-(2-piperidyl)-6,8-dichloro-2-trifluoromethyl-4-quinolinemethanol phosphate (WR-226,253 H,PO4). Interim report No. 131, U.S. Army medical research and development command contract No. DAMD-17–74-C-4036, Sept 23

    Google Scholar 

  • Hodgson JR, Kowalski MA, Goethem DV, Hainje M, Lee CC (1977c) Mutagenicity studies on a-diheptylaminomethy1–6-bromo-9-phenanthrene methanol hydrochloride (WR-33,063 HC1). Interim report No. 132, U.S. Army medical research and development command contract No. DAMD-17–74-C-4036, September 22

    Google Scholar 

  • Hodgson JR, Kowalski MA, Goethem DV, Hainje M, Lee CC (1977d) Mutagenicity studies on phenanthrene methanol (WR-122,455 HC1). Interim report No. 121, U.S. Army medical research and development command contract No. DAMD-17–74-C-4036, Aug 19

    Google Scholar 

  • Hodgson JR, Kowalski MA, Goethem DV, Hainje M, Lee CC (1977e) Mutagenicity studies on 1,3,-dichloro-6-trifluoromethyl-9-[lhydroxy-3-(dibutylamino) propyl] phenanthrene hydrochloride (WR-171,669 HC1). Interim report No. 124, U.S. Army medical research and development command contract No. DAMD-17–74-C-4036, August 31

    Google Scholar 

  • Hodgson JR, Kowalski MA, Goethem DV, Hainje M, Lee CC (1977 f) Mutagenicity studies on DL-threo-a-(2-piperidyl)-2-trifluoromethyl-6-(4-trifluoromethylphenyl)-4-pyridinemethanol phosphate (WR-180,409 H3PO4). Interim report No. 129, U.S. Army medical research and development command contract No. DAMD-17–74-C-4036, September 9

    Google Scholar 

  • Hodgson, JR, Kowalski MA, Goethem DV, Hainje M, Lee CC (1977g) Mutagenicity studies on 3-di-n-butylamino-1-[2,6-bis(4-trifluoromethylphenyl)-4-pyridyl] propanol methanesulfonate (WR-172,435 CH2S03H) Interim report No. 126, U.S. Army medical research and development command contract No. DAMD-17–74-C-4036, August 32

    Google Scholar 

  • Hodgson JR, Minor JL, Lee C-C, Chung H (1979) Pharmakokinetic studies on a new candidate antimalarial 3-di-n-butylamino-1-[2,6-bis(4-trifluoromethylphenyl)-4-pyridyl] propanol methanesulfonate, WR-172,435 CH3SO3H in rhesus monkeys. Toxicol Appl Pharmacol 48:No 1 Part 2 A8

    Google Scholar 

  • Jauch VR, Griesser E, Osterhelt G (1980) Metabolismus von Ro 21–5998 ( Mefloquine) bei der Ratte. Arzneimittelforsch 30:60–67

    PubMed  CAS  Google Scholar 

  • Jearnpipatkul A, Govitrapong P, Yuthavong Y, Wilairat P, Panijpan B (1980) Binding of antimalarial drugs to hemozoin from Plasmodium berghei. Experientia 36:1063–1064

    PubMed  CAS  Google Scholar 

  • Johnson JA, Barry KG (1979) WR-172,435 CH3SO3H:short term dosage, safety and tolerance:effect on the total and differential leukocyte counts following a single oral dose. Final report, addendum to experiment number 13, U.S. Army medical research and development command contract No. DAMD-17–75-C-5036

    Google Scholar 

  • Korte DW Jr, Heiffer MH, Kintner LD, Lee CC (1978) Comparative acute and subacute toxicities of erythro-a-(2-piperidyl)-2,8-bis(trifluoromethyl)-4-quinolinemethanol HC1, WR-142,490 HCI(mefloquine HC1) and its threo diastereomer WR-177,602 HC1, in dogs. Fed Proc Fed Am Soc Exp Biol 37:248

    Google Scholar 

  • Korte DW Jr, Heiffer MH, Hacker MP, Kintner LD, Hong CB, Lee CC (1979) Subchronic toxicity of the antimalarial drug, mefloquine hydrochloride (WR-142,490), in monkeys and dogs. Fed Proc Fed Am Soc Exp Biol 38:680

    Google Scholar 

  • LaMontagne MP, Markovac A, Blumbergs P (1974) Antimalarials. 6,Synthesis, anitmalarial activity, and configuration of racemic a-(2-piperidyl)-4-pyridinemethanols. J. Med Chem 17:519–523

    PubMed  CAS  Google Scholar 

  • Lee CC, Castles TR, Crawford CR, Landes AM (1967) Acute and subacute oral toxicities of 6,8-dichloro-2-(3’,4’dichlorophenyl)-a-(di-n-butylaminomethyl)-4-quinolinemethanol monohydrochloride (WR-30,090-E) in dogs. Interim report No. 13, U.S. Army medical research and development command contract No. DA-49–193-MD-2759, December 18

    Google Scholar 

  • Lee CC, Castles TR, Crawford CR, Landes AM (1968a) Acute and subacute oral toxicities of 6,8-dichloro-2-(3’,4’dichlorophenyl)-a-(di-n-butylaminomethyl)-4-quinolinemethanol monohydrochloride (WR-30,090-E) in dogs — further study. Interim report No. 19, U.S. Army medical research and development command contract No. DA-49193-MD-2759, April 26

    Google Scholar 

  • Lee CC, Castles TR, Crawford CR, Landes AM (1968b) Acute and subacute oral toxicities of 6,8-dichloro-2-(3’,4’dichlorophenyl)-a-(di-n-butylaminomethyl)-4-quinolinemethanol monohydrochloride (WR-30,090-E) in dogs — additional study. Interim report No. 19, U.S. Army medical research and development command contract No. DA-40193-MD-2759, February 20

    Google Scholar 

  • Lee CC, Castles TR, Crawford CR, Landes AM (1968c) Acute and subacute oral toxicities of 6,8-dichloro-2-(3’,4’dichlorophenyl)-α-(di-n-butylaminomethyl)-4-quinolinemethanol monohydrochloride (WR-30,090-E) in dogs - supplement. Interim report No. 19, U.S. Army medical research and development command contract No. DA-49–193MD-2759, July 20

    Google Scholar 

  • Lee CC, Castles TR, Landes AM, Cronin MC, Bristow RL (1970a) Acute and sub-acute oral toxicities of phenanthrene methanol, WR-122–455 (AV-17876) in rodents. Interim report No. 35, U.S. Army medical research and development command contract No. DA-49–193-MD-2759, July 24

    Google Scholar 

  • Lee CC, Castles TR, Landes AM, Cronin MC, Bristow RL (1970b) Acute and subacute oral toxicities of phenanthrene methanol, WR-122,455 (AV-17876), in dogs. Interim report No. 32, U.S. Army medical research and development command contract No. DA-49193-MD-2759, Jan 21

    Google Scholar 

  • Lee CC, Castles TR, Landes AM, Cronin MC, Bristow RL (1970c) Subacute oral toxicities of phenanthrene methanol, WR-122,455 (AV99065) in dogs. Interim report No. 38, U.S. Army medical research and development command contract No. DA-49–193-MD-2759, Oct 7

    Google Scholar 

  • Lee CC, Castles TR, Landes AM, Cronin MC, Bristow RL (1970d) Reversal toxicity study on phenanthrene methanol WR-122,455, in dogs. Interim Report No.36, U.S. Army medical research and development command contract No. DA-49–193-MD-2759, July 24

    Google Scholar 

  • Lee CC, Castles TR, Landes AM, Cronin MC, Coffelt J, Hutchcraft R (1971a) Subacute oral toxicity of 6,8-dichloro-2-(3’,4’-dichlorophenyl)-alpha-(di-n-butylaminomethyl)-4quinolinemethanol monohydrochloride WR-30,090 (AV-07996), in rats (84 days). Interim report No. 44, U.A. Army medical research and development command contract No. DA-49–193-MD-2759, June 21

    Google Scholar 

  • Lee CC, Castles TR, Landes AM, Cronin MC, Coffelt J, Hutchcraft R (1971b) Subacute oral toxicity of 6,8-dichloro-2-(3’,4’-dichlorophenyl)-α-(di-n-butylamino-methyl)-4quinolinemethanol monohydrochloride, WR-30,090 (AV-07996), in dogs (91 days). Interim report No.45, U.S. Army medical research and development command contract No. DA-49–193-MD-2759, June 24

    Google Scholar 

  • Lee CC, Kintner LD, Castles TR, Landes AM, Cronin MC, Hutchcraft R, Merle F (1972a) Acute and subacute oral toxicities of α-(2-piperidyl)-2,8-bis(trifluoromethyl)-4-quinolinemethanol hydrochloride, WR-142,490 (AY-65742), in dogs. Interim report No. 57, U.S. Army medical research and development command contract No. DA-49–193-MD2759, Jan 21

    Google Scholar 

  • Lee CC, Kintner LD, Castles TR, Landes AM, Cronin MC, Hutchcraft R, Merle F (1972b) Acute and subacute toxicities of α-(2-piperidyl)-2,8-bis(trifluoromethyl)-4-quinolinemethanol hydrochloride, WR-142,490(AY-65742), in rodents. Interim report No.56, U.S. Army medical research and development command contract No. DA-49–193-MD2759, Jan 20

    Google Scholar 

  • Lee CC, Kintner LD, Sanyer JL, Castles TR, Landes AM, Cronin MC, Merle F (1972c) Acute and subacute toxicities of 1,3-dichloro-6-trifluoromethyl-9-[1-hydroxy-3-(dibutylamino)propyl] phenanthrene hydrochloride, WR-171,669 (BB-41223), in rodents. Interim report No.65, U.S. Army medical research and development command contract No. DA-49–193-MD-2759, October 3

    Google Scholar 

  • Lee CC, Kintner LD, Sanyer JL, Castles TR, Landes AM, Cronin MC, Merle F (1972d) Acute and subacute oral toxicities of 1,3-dichloro-6-trifluoromethyl-9-[1-hydroxy-3(dibutylamino)-propyl] phenanthrene hydrochloride, WR-171,669 (BB-41223) in dogs. Interim report No.66, U.S. Army medical research and development command contract No. DA-49–193-MD-2759, October 17

    Google Scholar 

  • Lee CC, Kintner LD, Sanyer JL, Castles TR, Reddig TW, Girvin JD, Kowalski JJ, Buch-berger GL (1974a) Oral toxicity of a-(2-piperidyl)-2,8-bis(trifluoromethyl)-4-quinolinemethanol hydrochloride, WR-142,490, in rats at the completion of 52 weeks. Interim report No. 85, U.S. Army medical research and development command contract No. DAMD-17–74-C-4063

    Google Scholar 

  • Lee CC, Kintner LD, Sanyer JL, Castles TR, Reddig TW, Girvin JD, Kowalski JJ, Buch-berger GL (1974b) Oral toxicity of α-(2-piperidy1)-2,8-bis(trifluoromethyl)-4-quinolinemethanol hydrochloride, WR-142,490, in dogs at the completion of 52 weeks. Interim report No. 85, U.S. Army medical research and development command contract No. DAMD-17–74-C-4063, April 30

    Google Scholar 

  • Lee CC, Kintner LD, Sanyer JL, Reddig TW, Girvin JD, Buchberger GL, Seifert WK (1974c) Acute and subacute toxicity of 2,8-bis(trifluoromethyl)-4[1-hydroxy-3-(N-t-butylamino)-propyl]-quinoline phosphate, WR 184806, in rodents. Interim report No. 89, U.S. Army medical research and development command contract No. DAMD-17–74-C-4063

    Google Scholar 

  • Lee CC, Kintner LD, Sanyer JL, Reddig TW, Girvin JD, Buchberger GL, Seifert WK (1974d) Acute and subacute toxicity of 2,8-bis(trifluoromethyl)-4[1-hydroxy-3-(N-t-butylamino)-propyl]-quinoline phosphate, WR-184806, in dogs. Interim report No. 88, U.S. Army medical research and development command contract No. DAMD-17–74-C-4063

    Google Scholar 

  • Lee CC, Hwang SW, Kowalski JJ, Kintner LD, Bhandari JC, Reddig TW, Girvin JD, Kroeger VE, Kemp RD (1976a) Acute and subacute toxicities of DL-threo-α-(2-piperidyl)-2trifluoromethyl-6-(4-trifluoromethylphenyl)-4-pyridienemethanol phosphate, WR-180409 H3PO4, in rodents. Interim report No. 105, U.S. Army medical research and development command contract No. DAMD-17–74-C-4036, January 26

    Google Scholar 

  • Lee CC, Bhandari JC, Kowalski JJ, Kemp RD (1976b) Acute toxicity studies of DL-threoa-(2-piperidyl)-2-tri fluoromethyl-6-(4-trifluoromethylphenyl)-4-pyridinemethanol phosphate, WR-180409 H3PO4 in rats and dogs. Interim report No. 108, U.S. Army medical research and development contract No. DAMD-17–74-C-4036, April 13

    Google Scholar 

  • Lee CC, Kowalski JJ, Kintner LD, Bhandari JC, Reddig TW, Ellis ER, Kemp RD (1976c) Additional subacute oral toxicity of DL-threo-α-(2-piperidyl)-2-trifluoromethyl-6-(4trifluoromethylphenyl)-4-pyridine-methanol phosphate, WR-180409 H3PO4 in rodents. Interim report No. 105, U.S. Army medical research and development command contract No. DAMD-17–74-C-4036, August 5

    Google Scholar 

  • Lee CC, Hwang SW, Kowalski JJ, Kintner LD, Bhandari JC, Reddig TW, Girvin JD, Kroeger VE, Kemp RD (1976d) Acute and subacute oral toxicity of DL-threo-α-(2-piperidyl)2-trifluoromethyl-6-(4-trifluoromethylphenyl)-4-pyridinemethanol phosphate, WR-180409 H3PO4 in dogs. Interim report No. 106, U.S. Army medical research and development command contract No. DAMD-17–74-C-4036, March 12

    Google Scholar 

  • Lee CC, Kowalski JJ, Kintner LD, Bhandari JC, Reddig TW, Ellis ER (1976e) Additional subacute oral toxicity of DL-threo-α-(2-piperidyl)-2-trifluoromethyl-6-(4-trifluoromethylphenyl)-4-pyridienemethanol phosphate, WR-180409 H3PO4, in dogs. Interim report No. 106, U.S. Army medical research and development command contract No. DAMD-17–74-C-4036, September 29

    Google Scholar 

  • Lee CC, Kowalski JJ, Kintner LD, Bhandari JC, Reddig TW, Girvin JD, Ellis ER, Castillo EA, Kroeger VE, Kemp RD (1976f) Acute and subacute toxicities of 3-di-N-butylamino-1-[2,6-bis(4-tri-fluoromethylphenyl)-4-pyridiyl]-propanol methanesulfonte, WR-172435 CH3SO3H, in rodents. Interim report No. 111, U.S. Army medical research and development command, contract No. DAMD-17–74-C-4036, July 30

    Google Scholar 

  • Lee CC, Hacker MP, Elliott CL (1979a) Acute oral and intraperitoneal toxicity of α-(2-piperidyl)-6,8-dichloro-2-trifluoromethyl-4-quinolinemethanol (WR-226,253) methanesulfonate hemihydrate in rats, mice and guinea pigs. Interim report No.144, U.S. Army medical research and development command contract No. DAMD-17–74C-4036, March 1

    Google Scholar 

  • Lee CC, Ellis HV III, Hacker MP, Kintner LD, Hong CB, Elliot CL, Ellis ER, Castillo EA (1979b) Toxicity of α-(2-piperidyl)-6,8-dichloro-2-trifluoro methyl-4-quinoline-methanol (WR-226253) methanesulfonate hemihydrate when fed to male rats for 90 days. Interim report No. 151, U.S. Army medical research and development command contract No. DAMD-17–74-C-4036, November 29

    Google Scholar 

  • Lutz RE, Bailey PS, Clark MT, Codington JF, Deinet AJ, Freek JA, Harnest GH, Leake NH, Martin TA, Russell Jr, Salsbury JM, Shearer NH Jr, Smith JD, Wilson JW III (1946) Antimalarials. Alpha-alkyl and dialkyaminomethyl-2-phenyl-4-quinolinemethanols. J Am Chem Soc 68:1813–1831

    PubMed  Google Scholar 

  • Macomber PB, O’Brien RL, Hahn FE (1966) Chloroquine:physiological basis of drug resistance in Plasmodium berghei. Science 152:1374–1375

    PubMed  CAS  Google Scholar 

  • Martin DC, Arnold JD, Clyde DF, Al Ibrahim M, Carson PE, Rieckmann KH, Willerson D Jr (1973) A quinoline methanol (WR-30090) for treatment of acute malaria. Antimicrob Agents Chemother 3:214–219

    PubMed  CAS  Google Scholar 

  • May EL, Mosettig E (1946) Attempts to find new antimalarials. XVIII. Amino alcohols of the type-CHOHCH2NR2 derived from 3-bromo-10-acetylphenanthrene. J Org Chem 11:627–630

    PubMed  CAS  Google Scholar 

  • McConnel WR, Fumer RL (1977) Studies on the absorption, distribution, metabolism, excretion, [14C]WR-180,409 H3PO4 in rhesus monkeys. Toxicol Appl Pharmacol 41:166–167

    Google Scholar 

  • Mead J, Koepfli JB (1944) The structure of a new metabolic derivative of quinine. J Biol Chem 154:507–515

    CAS  Google Scholar 

  • Mendenhall DW, Higuchi T, Sternson LA (1979) Analysis of hydrophobic amine antimalarials in biological fluids with the plastic ion-selective electrode. J Pharm Sci 68:746–750

    PubMed  CAS  Google Scholar 

  • Merkli B, Richle RW (1980) Studies on the resistance to single and combined antimalarials in the Plasmodium berghei mouse model. Acta Tropica 37:228–231

    PubMed  CAS  Google Scholar 

  • Merkli B, Richle R, Peters W (1980) The inhibitory effect of a drug combination on the development of mefloquine resistance in Plasmodium berghei. Ann Trop Med Parasitol 74:1–9

    PubMed  CAS  Google Scholar 

  • Minor JL, Short RD, Heiffer MH, Lee CC (1976) Reproductive effects of mefloquine HCI(MFQ) in rats and mice. Pharmacologist 18:171

    Google Scholar 

  • Most H, Montouri WA (1975) Rodent systems (Plasmodium berghei–Anopheles stephensi) for screening compounds for potential causal prophylaxis. Am J Trop Med Hyg 24:179–182

    PubMed  CAS  Google Scholar 

  • Nakagawa T, Higuchi T, Haslam JL, Shaffer RD, Mendenhall DW (1979) GLC Determination of whole blood antimalarial concentrations. J Pharm Sci 68:718–721

    PubMed  CAS  Google Scholar 

  • Nodiff EA, Tanabe K, Seyfried C, Matsuura S, Kondo Y, Chen EH, Tyagi MP (1971) Antimalarial phenanthrene amino alcohols. 1. Fluorine-containing 2- and 6-substituted 9-phenanthrenemethanols. J Med Chem 14:921–925

    PubMed  CAS  Google Scholar 

  • Novotny JF, Starks FW (1977) Synthesis of candidate antimalarials. Report No. 12, Annual summary report, U.S. Army medical research and development command contract No. DADA17–73-C-3159

    Google Scholar 

  • Ohnmacht CJ, Patel AR, Lutz RE (1971) Antimalarials. 7. Bis(trifluoromethyl)-a-(2-piperidy1)-4 quinolinemethanols. J Med Chem 14:926–928

    PubMed  CAS  Google Scholar 

  • Okada H, Stella V, Haslam J, Yata N (1975) Photolytic degradation of α-[(dibutylamino)methyl]-6,8-dichloro-2-(3’,4’-dichlorophenyl)-4-quinoline methanol:an experimental antimalarial. J Pharm Sci 64:1665–1667

    PubMed  CAS  Google Scholar 

  • Olmstead EJ, Panter JW, Boykin DW, Wilson WD (1975) Complex formation between naphthothiopheneethanolamines and deoxyribonucleic acids. Biochemistry 14:521–516

    PubMed  CAS  Google Scholar 

  • Olsen RE (1972) Antimalarial activity and conformation of erythro-and threo-α-(2-pi peri-dyl)-3,6-bis(trifluoromethyl)-9-phenanthrenemethanol. J Med Chem 15:207–208

    PubMed  CAS  Google Scholar 

  • Osdene TS, Russell PB, Rane L (1967) 2,4,7-triamino-6-ortho-substituted arylpteridines. A new series of potent antimalarial agents. J Med Chem 10:431–434

    CAS  Google Scholar 

  • Panter JW, Boykin DW, Wilson WD (1973) Effect of ring and side chain substitutents on the binding of naphthothiopheneethanolamines to deoxyribonucleic acid. Spectrophotometric studies. J Med Chem 16:1366–1369

    CAS  Google Scholar 

  • Pearlman EJ, Doberstyn EB, Sudsok S, Thiemanun W, Kennedy RS, Canfield CJ (1980) Chemosuppressive field trials in Thailand IV. The suppression of Plasmodium falciparum and Plasmodium vivax parasitemias by mefloquine (WR142,490, a 4-quinolinemethanol). Am J Trop Med Hyg 29:1131–1137

    PubMed  CAS  Google Scholar 

  • Pearson DE, Rosenberg AA (1975) Potential antimalarials. 9. Resolution of α-diheptylaminomethyl-6-bromo-9-phenanthrenemethanol by an unusual method. J Med Chem 18:523–524

    PubMed  CAS  Google Scholar 

  • Peters W (1965) Drug resistance in Plasmodium berghei (Vincke and Lips, 1948). I Chloroquine resistance. Exp Parasitol 17:80–89

    PubMed  CAS  Google Scholar 

  • Peters W, Porter M (1976) The chemotherapy of rodent malaria, XXVI The potential value of WR-122,455 (a 9-phenanthrenemethanol) against drug-resistant malaria parasites. Ann Trop Med Parasitol 70:271–281

    PubMed  CAS  Google Scholar 

  • Peters W, Portus JH, Robinson BL (1975a) The chemotherapy of rodent malarial, XXII The value of drug-resistant strains of P. berghei in screening for blood schizontocidal activity. Ann Trop Med Parasitol 69:155–171

    PubMed  CAS  Google Scholar 

  • Peters W, Davies EE, Robinson BL (1975b) The chemotherapy of rodent malaria, XXIII. Causal prophylaxis, part II:practical experience with P. berghei nigeriensis in drug screening. Ann Trop Med Parasitol 69:311–328

    PubMed  CAS  Google Scholar 

  • Peters W, Howells RE, Portus J, Robinson BL, Thomas S, Warhurst DC (1977a) The chemotherapy of rodent malaria, XXVII Studies on mefloquine (WR-142,490). Ann Trop Med Parasitol 71:407–418

    PubMed  CAS  Google Scholar 

  • Peters W, Portus J, Robinson BL (1977b) The chemotherapy of rodent malaria, XXVIII. The development of resistance to mefloquine (WR142,490). Ann Trop Med Parasitol 71:419–427

    PubMed  CAS  Google Scholar 

  • Pinder RM, Burger A (1968) Antimalarials. II. α-(2-piperidyl)- and -(2-pyridyl)-2trifluoromethyl-4-quinolinemethanols. J Med Chem 11:267–269

    PubMed  CAS  Google Scholar 

  • Porter M, Peters W (1976) The chemotherapy of rodent malaria, XXV Antimalarial activity of WR-122,455 (a 9-phenanthrenemethanol) in vivo and in vitro. Ann Trop Med Parasitol 70:259–270

    PubMed  CAS  Google Scholar 

  • Powers MD (1968a) 20-day oral toxicity in rats. Final report, U.S. Army medical research and development command contract No. DADA-17–68-C-8069, February 9

    Google Scholar 

  • Powers MB (1968b) Two-week oral toxicity-rats. Final report, U.S. Army medical research and development command contract No. DADA-17–68-C-8069, August 21

    Google Scholar 

  • Powers MB (1968c) 14-day oral administration-monkeys. Final report, U.S. Army medical research and development command contract No. DADA-17–68-C-8069, August 15

    Google Scholar 

  • Powers MB (1970) Four–week oral toxicity study–monkeys WR122,455 (AV 17876). Report No. 35, U.S. Army medical research and development command contract No. DADA–17–68–8069. May 22

    Google Scholar 

  • Pullman TN, Eichelberger L, Alving AS, Jones R Jr, Craige B Jr, Whorton CM (1948) The use of SN-10,275 in the prophylaxis and treatment of sporozoite-induced vivax malaria ( Chesson strain ). J Clin Invest XX VII:12–16

    Google Scholar 

  • Quimby DJ (1981) Preparation of 2-trifluoromethyl cinchoninic acids. US Patent 4,251,661 Feb 17

    Google Scholar 

  • Rapport MM, Senear AE, Mead JF, Koepfli JF (1946) The synthesis of potential antimalarials. 2-phenyl-a-(2-piperidyl)-4-quinolinemethanols. J Am Chem Soc 68:2697–2703

    PubMed  CAS  Google Scholar 

  • Reba RC, Barry KG (1976a) Final report, experiment 2:WR184,806 H3PO4 short term safety and tolerance (single rising dose levels). U.S. Army medical research and development command contract No. DAMD-17–75-C-5036, Feb 19

    Google Scholar 

  • Reba RC, Barry KG (1976b) Final report, experiment 2:WR184,806 H3PO4 short term safety and tolerance (multiple dose). U.S. Army medical research and development command contract No. DAMD-17–75-C-5036, June 2

    Google Scholar 

  • Reba RC, Barry KG (1977) Final report experiment No. 7:WR180,409 H3PO4 short term dosage safety and tolerance rising single dose levels. U.S. Army medical research and development command contract No. DAMD-17–75-C-5036

    Google Scholar 

  • Reba RC, Barry KG (1978) WR172,435 CH2SO3:short term dosage, safety and tolerance:single oral dose, rising dose levels. Final report, experiment Number 13, U.S. Army medical research and development command contract No. DAMD-17–75-C-5036, December

    Google Scholar 

  • Richle RW (1980) Chemotherapeutic activity of mefloquine hydrochloride in experimental Plasmodium berghei malaria in mice. Current chemotherapy and infectious disease. Proceedings of the 11th ICC and the 19th ICAAC American Society of Microbiology

    Google Scholar 

  • Rieckmann KH, Trenholme GM, Williams RL, Carson PE, Frischer H, Desjardins RE (1974) Prophylactic activity of mefloquine hydrochloride (WR142490) in drug-resistant malaria. Bull WHO 51:375–377

    PubMed  CAS  Google Scholar 

  • Rieckmann KH, Campbell GH, Sax LJ, Mrema JE (1978) Drug sensitivity of Plasmodium falciparum. Lancet 1:22–23

    PubMed  CAS  Google Scholar 

  • Rinehart J, Arnold J, Canfield CJ (1976) Evaluation of two phenanthrenemethanols for antimalarial activity in man:WR-122,455 and WR-171,669. Am J Trop Med Hyg 25:769–774

    PubMed  CAS  Google Scholar 

  • Rothe WE, Jacobus DP (1968) Laboratory evaluation of the phototoxic potency of quinolinemethanols. J Med Chem 11:366–368

    PubMed  CAS  Google Scholar 

  • Rozman RS, Canfield CJ (1979) New experimental antimalarial drugs. Adv Pharmacol Chemother 16:1–43

    PubMed  CAS  Google Scholar 

  • Rozman RS, Berman A, Hutchinson A, Clinton-Molero G (1971) Uptake and excretion of antimalarial phenanthrene methanols. Fed Proc Fed Am Soc Exp Biol 30:335

    Google Scholar 

  • Rozman RS, Molek NA, Koby R (1978) The absorption, distribution, and excretion in mice of the antimalarial mefloquine, erythro-2,8-bis(trifluoromethyl)-α-(2-piperidyl)-4quinolinemethanol hydrochloride. Drug Metab Dispos 6:654–658

    PubMed  CAS  Google Scholar 

  • Ruiz R, Belej M, Aviado DM (1970) Cardiopulmonary effects of antimalarial drugs II. Phenanthrenemethanols. Toxicol Appl Pharmacol 17:118–129

    PubMed  CAS  Google Scholar 

  • Sadavongvivad C, Aviado DM (1969) Influence of chloroquine and phenanthrene methanols (WR-33063) on the content of biogenic amines in the mouse lung. Milit Med [Special Issue] 134:1106–1118

    CAS  Google Scholar 

  • Schmidt LH, Rossan RN, Fisher KF (1963) The activity of a repository form of 4,6-diamino- 1-(p-chlorophenyl)-1,2-dihydro-2,2-dimethyl-s-triazine against infections with Plasmodium cynomolgi. Am J Trop Med Hyg 12:494–503

    PubMed  CAS  Google Scholar 

  • Schmidt LH, Crosby R, Rasco J, Vaughan D (1978a) Antimalarial activities of various 4quinolinemethanols with special attention to WR-142,490 (mefloquine). Antimicrob Agents Chemother 13:1011–1030

    PubMed  CAS  Google Scholar 

  • Schmidt LH, Crosby R, Rasco J, Vaughan D (1978b) Antimalarial activities of the 4-quinolinemethanols WR-184,806 and WR-226,253. Antimicrob Agents Chemother 14:680–689

    PubMed  CAS  Google Scholar 

  • Schmidt LH, Crosby R, Rasco J, Vaughan D (1978c) Antimalarial activities of various 9phenanthrenemethanols with special attention to WR-122,455 and WR-171,669. Antimicrob Agents Chemother 14:292–314

    PubMed  CAS  Google Scholar 

  • Schmidt LH, Crosby R, Rasco J, Vaughan D (1978d) Antimalarial activities of various 4pyridinemethanols with special attention to WR-172,435 and WR-180,409. Antimicrob Agents Chemother 14:420–435

    PubMed  CAS  Google Scholar 

  • Schwartz DE (1980) Quantitative determination of the antimalarial drug mefloquine and of its main metabolite in plasma by direct densiometric measurement on thin-layer chromatographic plates. In: Frigerio A, McCamish M (eds) Recent developments in chromatography and electrophoresis, 10. Elsevier, Amsterdam, p 69

    Google Scholar 

  • Schwartz DE, Weber W, Richard-Lenoble D, Gentilini M (1980) Kinetic studies of mefloquine and one of its metabolites, RO 21–5104, in the dog and in man. Acta Tropica 37:238–242

    PubMed  CAS  Google Scholar 

  • Segal HE, Chinvanthananond P, Laixuthal B, Phintuyothin P, Pearlman EJ, Na-Nakorn A, Castaneda BF (1974) Preliminary study of WR-33063 in the treatment of falciparum malaria in northeast Thailand. Am J Trop Med Hyg 23:560–564

    PubMed  CAS  Google Scholar 

  • Smith CC, Weigel WW (1971a) Conversion of tritium to H2O following oral administration of two labelled phenanthrenemethanols to primates. Pharmacologist 13:269

    Google Scholar 

  • Smith CC, Weigel W (1971b) Metabolism of a new, tritium-labeled phenanthrene methanol with pronounced antimalarial activity. Toxicol Appl Pharmacol 19:364

    Google Scholar 

  • Smith CC, Wolfe GF, Mattingly SF (1972) Excretion of three antimalarial drugs, WR-38,839, WR-33,063, and WR-122455, in rhesus monkeys with chronic biliary cannulae. Toxicol Appl Pharmacol 22:291

    Google Scholar 

  • Stampfli H, von Bredow J, Osuch J, Heiffer M (1979) A multi-component solvent system for the analysis of a candidate antimalarial by normal phase HPLC. J Liq Chromatogr 2:53–65

    CAS  Google Scholar 

  • Stella V, Haslam J, Yata N, Okada H, Lindenbaum S, Higuchi T (1978) Enhancement of bioavailability of a hydrophobic amine antimalarial by formulation with oleic acid in a soft gelatin capsule. J Pharm Sci 67:1375–1377

    PubMed  CAS  Google Scholar 

  • Strube R (1975) The search for new antimalarial drugs. J Trop Med Hyg 78:171–185

    PubMed  CAS  Google Scholar 

  • Sweeney TR (1981) The present status of malaria chemotherapy:mefloquine, a novel antimalarial. Med Res Rev 1:281–301

    PubMed  CAS  Google Scholar 

  • Teague RS, Mundy RL (1972a) Study of the effects of a large dose of WR-171,669AC (BB 41223) in the anesthetized mouse. Interim report No. 35, U.S. Army medical research and development command contract No. DADA-17–69-C-7136. June 2

    Google Scholar 

  • Teague RS, Mundy RL (1972b) Effects of the sub-acute administration of compound WR171,669AC (BB 41223) in large oral doses to the mouse. Interim report No. 36, U.S. Army medical research and development command contract No. DADA-17–69-C-7136, August 2

    Google Scholar 

  • Thakker KD, Higuchi T, Sternson LA (1979) Loss of hydrophobic amine from solution by adsorption onto container surfaces. J Pharm Sci 68:93–95

    PubMed  CAS  Google Scholar 

  • Thompson PE (1972) Studies on a quinolinemethanol (WR 30,090) and on a phenanthrenemethanol (WR33,063) against drug-resistant Plasmodium berghei in mice. Proc Helminthol Soc Washington [Special Issue] 39:297–308

    CAS  Google Scholar 

  • Thong YH, Ferrante A, Rowan-Kelly B, O’Keefe DE (1979) Effect of mefloquine on the immune response in mice. Trans R Soc Trop Med Hyg 73:388–390

    PubMed  CAS  Google Scholar 

  • Trenholme GM, Wiliams RL, Desjardins RE, Frischer H, Carson PE, Rieckmann KH (1975) Mefloquine (WR142,490) in the treatment of human malaria. Science 190:792–794

    PubMed  CAS  Google Scholar 

  • Warhurst DC, Baggaley (1972) Autophagic vacuole formation in P. berghei in vitro. Trans R Soc Trop Med Hyg 66:5

    CAS  Google Scholar 

  • Warhurst DC, Thomas SC (1975) Pharmacology of the malaria parasite — a study of dose-response relationships in chloroquine-induced autophagic vacuole formation in Plasmodium berghei. Biochem Pharmacol 24:2047–2056

    PubMed  CAS  Google Scholar 

  • Warhurst DC, Robinson BL, Howells RE, Peters W (1971) The effect of cytotoxic agents on autophagic vacuole formation in chloroquine-treated malaria parasites (Plasmodium berghei). Life Sci 10:761–771

    CAS  Google Scholar 

  • Warhurst DC, Homewood CA, Peters W, Baggaley VC (1972) Pigment changes in Plasmodium berghei as indicators of activity and mode of action of antimalarial drugs. Proc. Helminthol Soc Washington [Special Issue] 39:271–278

    CAS  Google Scholar 

  • Weigel WW, Smith CC (1973) Fate of a-(2-piperidyl)-3,6-bis(trifluoromethyl)-9-phenanthrene methanol in owl monkeys. Proc 5th Int Congr Pharmacol 1972 Abstract No 1488

    Google Scholar 

  • Windheuser JJ, Haslam JL (1976) Bioavailability studies of several formulations of WR171,669 in beagle dogs. Interim report No. 22, U.S. Army medical research and development command contract No. DADA17–73-C-3125, October

    Google Scholar 

  • Wiselogle FY (1946) A survey of antimalarial drugs. Edwards, Ann Arbor

    Google Scholar 

  • Yanko WH, Deebel GF (1980) 14C-Labelled antimalarials. I. Synthesis of dl-erythro- and threo-α-(2-piperidyl)-2,8-bis(trifluoromethyl)-4-quinolinemethanol-α-14C. J Label Cpds XVII:431–437

    Google Scholar 

Download references

Authors
  1. T. R. Sweeney
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, Great Britain

    Wallace Peters M.D., DSc, FRCP, DTM & H (Professor of Medical Protozoology) (Professor of Medical Protozoology)

  2. Wellcome Research Laboratories, Ravens Lane, Berkhamsted, Herts., HP4 2DY, Great Britain

    William H. G. Richards BSc, Ph. D. (Manager, Scientific Advisory Services) (Manager, Scientific Advisory Services)

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Sweeney, T.R. (1984). Drugs with Quinine-like Action. In: Peters, W., Richards, W.H.G. (eds) Antimalarial Drug II. Handbook of Experimental Pharmacology, vol 68 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69254-3_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-69254-3_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-69256-7

  • Online ISBN: 978-3-642-69254-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation